PostJune 23, 2023MuReva Phototherapy presents data from pilot study of company’s photobiomodulation device during 2023 MASCC Annual MeetingNewsLarry Yost
PostApril 23, 2022MuReva Phototherapy to present at Five•Ten•Thirty program during San Diego Innovation DayNewsLarry Yost
PostApril 23, 2022MuReva Phototherapy Selected as One of Top Emerging Life Sciences Companies in Southern CaliforniaNewsLarry Yost
PostDecember 22, 2020MuReva Phototherapy gains investment from the Angel Physicians Fund and adds Manish Bhandari, MD, E-MBA to Board of DirectorsNewsLarry Yost
PostSeptember 2, 2020MuReva Phototherapy Awarded 1st Place at KJK New Venture Pitch contest during Cleveland Smart Business Dealmakers ConferenceNewsLarry Yost
PostJanuary 29, 2020MuReva Phototherapy announces initiation of clinical study in patients with head and neck cancerNewsLarry Yost
PostJanuary 24, 2020MuReva Phototherapy completes NIH Commercialization Accelerator ProgramNewsLarry Yost
PostJune 15, 2019MuReva Phototherapy’s CEO included in Crain’s Cleveland Business’ list of “Twenty in their 20s”NewsLarry Yost
PostMarch 3, 2019Crain’s Cleveland Business – Lumitex powers up phototherapy startup MuRevaNewsLarry Yost
PostSeptember 13, 2018MuReva Phototherapy Awarded Phase II Grant for Photobiomodulation Therapy DeviceNewsLarry Yost
